Cryosite Ltd (CTE)
CTE Chart
Snapshot
CTE's Principal Activity is the provision of temperature-controlled storage, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns management, comparator sourcing, import, export, validated transport solutions and biological storage to the clinical trials, research and pharmaceutical industry, Provision of long term storage for cord blood and tissue samples.
Share Price Activity
| Last (Price) | |
| Change | 0.00 (0.00) |
| Bid / Ask | - |
| Volume | |
| Volume (4w avg) | |
| Turnover | |
| Open | |
| Day Range | - |
| VWAP | |
| Prev Close | |
| Last Trade |
Performance
| 1 Week | |
| 1 Month | |
| 2021 YTD | |
| 1 Year | |
| vs Sector (1yr) | +31.66% |
| vs ASX 200 (1yr) | +13.34% |
Size
| Market Capitalisation | |
| ASX Rank | 1,846 of 2,319 |
| Sector Rank | 174 of 199 |
Announcements
| Date | Heading | Pages | File Size | Time |
|---|---|---|---|---|
Corporate Overview
Cryosite Limited (CTE) is into provision of supply chain logistics, management of pharmaceutical products used in clinical trials, management of biological materials and long-term storage of cord blood and tissue samples. Cryosite operates through Clinical Trials & Biological Storage and Logistics and Cord Blood and Tissues Storage.
Incorporation Details
Incorporated in NSW in December 1999.
Corporate Details
| Head Office | South Granville NSW 2142 |
| Website | www.cryosite.com |
| Registry | Link Market Services |
| Auditor | Mazars Risk & Assurance Pty Limited |
| Date Listed | 9 May 2002 |
Upcoming Calendar (Forecasted)
| Date | Event |
|---|---|
| 24/02/2022 | Report (Interim) |
| 24/08/2022 | Report (Prelim) |
| 24/08/2022 | Report (Annual) |
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
| Key Data | |
|---|---|
| DPS(TTM) | $0.00 |
| Gross DPS(TTM) | $0.00 |
| Dividend yield |
|
| Gross yield |
|
| Payout Ratio | 0% |
| DRP | No |
| DRP Features | -- |
Directors & Management
Directors & Management
Director Transactions
CTE directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of CTE directors.
Shareholder Info
Top 20 Shareholders
Data supplied by Morningstar and accurate on Aug 16, 2021.
It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.
All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).
Shareholder Distribution
As reported in the most recent Annual Report.
| Holding Size | 1 - 1,000 | 1,001 - 5,000 | 5,001 - 10,000 | 10,001 - 100,000 | 100,001+ | Total |
|---|---|---|---|---|---|---|
| No. of Shareholders | 42 | 241 | 64 | 105 | 37 | 489 |
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
| Name | Last Notice | Total Shares | Shares Held (%) |
|---|---|---|---|
| Robins Super Fund | 16/08/2021 | 2,800,000 | 5.98 |
| DMX Asset Management Limited | 16/08/2021 | 2,370,973 | 5.06 |
| Andrew John Kroger | 06/09/2021 | 20,266,964 | 41.52 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
| Date | Name | Bought | Previous % | New % |
|---|---|---|---|---|
| 17-06-21 | Andrew John Kroger | 83,133 | 43.07 | 43.25 |
| 03-06-21 | Andrew John Kroger | 473,325 | 42.06 | 43.07 |
| 01-06-21 | Andrew John Kroger | 820,894 | 40.31 | 42.06 |
| 12-05-21 | Robins Super Fund | 2,800,000 | -- | 5.92 |
| 11-03-21 | DMX Asset Management Limited | 2,770,973 | -- | 5.91 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
| Date | Name | Sold | Previous % | New % |
|---|---|---|---|---|
| 09-03-21 | Cell Care Australia Pty Ltd | 546,193 | 15.9 | 14.8 |
| 05-03-21 | Cell Care Australia Pty Ltd | 712,607 | 17.4 | 15.9 |
| 23-02-21 | Cell Care Australia Pty Ltd | 522,393 | 18.6 | 17.4 |
| 16-02-21 | Cell Care Australia Pty Ltd | 534,995 | 19.7 | 18.6 |
Historical Data
Share Price History
| Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
Historical Data
| Year | Closing Price | Last Trade |
|---|---|---|
| 2020 | $0.13 | 30 June |
| 2019 | $0.05 | 28 June |
| 2018 | $0.09 | 29 June |
| 2017 | $0.16 | 28 June |
| 2016 | $0.21 | 28 June |
| 2015 | $0.35 | 30 June |
| 2014 | $0.36 | 30 June |
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.